SOPHiA GENETICS SA (NASDAQ: SOPH) is a publicly traded corporation rather than a privately owned single enterprise. Its ownership structure is distributed among institutional asset management firms, mutual funds, venture capital funds that backed its early growth, executive insiders, and public retail investors trading shares on the Nasdaq global market.